- Home
- DHY vs OSUR Comparison
DHY vs OSUR Comparison
Compare DHY & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DHY | OSUR |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.4M | 207.2M |
| IPO Year | 1998 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DHY | OSUR |
|---|---|---|
| Price | $1.75 | $4.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 660.6K | ★ 838.4K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.74 | $2.08 |
| 52 Week High | $2.16 | $4.33 |
Technical Indicators
Market Signals| Indicator | DHY | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 69.86 |
| Support Level | $1.75 | $2.93 |
| Resistance Level | $2.05 | N/A |
| Average True Range (ATR) | 0.02 | 0.22 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 37.50 | 78.72 |
Price Performance
Historical ComparisonAbout DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.